Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir
Article in Infectious Diseases and Therapy (June 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Infectious Diseases and Therapy (June 2024)
Article in Cochrane Database of Systematic Reviews (November 2023)
Article in Microbiology Spectrum (September 2023)